RecallHawk

CEFAZOLIN (CEFAZOLIN SODIUM)

BAXTER HLTHCARE CORP

Summary

FDA approved CEFAZOLIN (CEFAZOLIN SODIUM) by BAXTER HLTHCARE CORP. NDA (New Drug) approval (Efficacy) on 2024-05-31. SOLUTION, INTRAVENOUS.

Details

Source

Drug Approval

External ID

NDA207131-10

Action Date

2024-05-31

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

CEFAZOLIN (generic: CEFAZOLIN SODIUM), SOLUTION, INTRAVENOUS. Application: NDA207131

Context & Analysis

BAXTER HLTHCARE CORP has 15 FDA actions in our database.

Frequently Asked Questions

How often does BAXTER HLTHCARE CORP have FDA actions?

BAXTER HLTHCARE CORP has 15 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA207131-10" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions